NETTLEHAM MEDICAL PRACTICE
14 LODGE LANE, NETTLEHAM, LINCOLN
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 31 | 40 | 77.5% | |
| HF 4 | 2011 | 28 | 29 | 96.6% | |
| HF 4 | 2012 | 37 | 40 | 92.5% | |
| HF 4 | 2013 | 42 | 54 | 77.8% | |
| HF004 | 2014 | 5 | 5 | 100.0% | |
| HF004 | 2015 | 16 | 17 | 94.1% | |
| HF004 | 2016 | 23 | 26 | 88.5% | |
| HF004 | 2017 | 39 | 45 | 86.7% | |
| HF004 | 2018 | 53 | 58 | 91.4% | |
| HF004 | 2019 | 58 | 65 | 89.2% | |
| HF004 | 2020 | 72 | 79 | 91.1% | |
| HF006 | 2021 | 82 | 93 | 88.2% | |
| HF006 | 2022 | 81 | 84 | 96.4% | |
| HF006 | 2023 | 93 | 96 | 96.9% |
